| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 02/15/2005 | CA2265539C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 02/10/2005 | US20050033047 such as 2-dimethylaminocarbonyl-5-nitro-n-4-[(4,6-dimethoxypyrimidin-2-yl)aminocarbonyl]benzene-sulfonamide via halogenation, ammonolysis, reduction, and reaction with carbamates; herbicides; plant growth regulators |
| 02/10/2005 | US20050032881 Novel non-psychotropic cannabinoids |
| 02/10/2005 | US20050032797 Fluorinated di-aryl urea compounds |
| 02/09/2005 | EP1503993A2 Compounds, methods and compositions |
| 02/09/2005 | EP1421080B1 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides |
| 02/09/2005 | EP1087951B1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 02/09/2005 | CN1578771A Developer components and their use for dyeing keratinic fibers |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1576274A Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/09/2005 | CN1188211C Preparation and use of ionic liquids in microwave-assisted chemical transformation |
| 02/08/2005 | US6852761 Inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular |
| 02/08/2005 | US6852229 Filtration; for prevention of destruction of catalyst |
| 02/08/2005 | CA2265489C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 02/08/2005 | CA2097208C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 02/03/2005 | US20050027121 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 02/02/2005 | EP1501803A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 02/02/2005 | EP1501794A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | EP1137413B1 Non-peptide antagonists of glp-1 receptor and methods of use |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/25/2005 | US6846930 Antiinflammatory agents; antiarthritic agents; rheumatic diseases; anticancer agents |
| 01/25/2005 | US6846925 Colchinol derivatives as angiogenesis inhibitors |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | CA2129455C Orally active azole derivatives |
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/19/2005 | EP1497298A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents |
| 01/19/2005 | EP1497286A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| 01/19/2005 | EP1497281A2 Azole derivatives as antifungal agents |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1497269A1 Substituted 2-phenyl-3(2h)-pyridazinones |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1395579B1 Method for producing triazolyl methyl oxiranes |
| 01/19/2005 | CN1185242C Ligand and complex for catalytically bleaching substate |
| 01/19/2005 | CN1185230C N-substituted carbamoyloxyalkyl-azolium derivs. |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/18/2005 | US6844404 Catalyst compositions for the polymerization of olefins |
| 01/18/2005 | US6844367 Benzamides and related inhibitors of factor Xa |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | US20050010048 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050005840 Production of ionic liquids |
| 01/12/2005 | EP1495036A1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates |
| 01/12/2005 | EP1495035A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183989C Reaction crystallizing method for improving grain size |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841304 Dissolves other salts, in particular metallic salts, such as lithium salts, to give highly conductive solutions |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004152 Thiazole compounds useful as inhibitors of protein kinase |
| 01/06/2005 | US20050004134 Adenosine antagonists; having 6-oxo-1,6-dihydro-3-pynidazinyl functionality; synthesis |
| 01/06/2005 | US20050004123 Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/05/2005 | EP1492772A1 Farnesyl protein transferase inhibitors as antitumor agents |
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | CN1561339A Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives |
| 01/05/2005 | CN1560051A 取代吡唑化合物 A substituted pyrazole compound |
| 01/05/2005 | CN1183174C Use of cationic copolymers for unsaturated acids and N-vinylimidazolium salts in cosmetic hair formulations |
| 01/05/2005 | CN1183114C Quinoline derivatives and quinazoline derivatives |
| 01/04/2005 | US6838464 Inhibitor of cyclin-dependent kinase |
| 01/04/2005 | US6838414 Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 01/04/2005 | CA2124696C Vasopressin antagonist and oxytocin antagonist |
| 12/30/2004 | US20040267027 Reacting imidazole and triphenyl carbinol in solid phase under microwave energy; for production of bifonazole |
| 12/30/2004 | US20040267024 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266774 Amide compounds |
| 12/30/2004 | US20040262578 Ionic liquids |
| 12/29/2004 | EP1334094B1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 12/29/2004 | EP1163209A4 Compounds and compositions for delivering active agents |
| 12/29/2004 | EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
| 12/29/2004 | EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase |
| 12/28/2004 | US6835739 Benzamides and related inhibitors of factor Xa |
| 12/28/2004 | US6835726 For therapy of viral infections, particularly human Cytomegalovirus infection |
| 12/23/2004 | WO2004071390A3 Piperazine-2-carboxamide derivatives |
| 12/23/2004 | US20040259904 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example |
| 12/23/2004 | US20040255403 Primary intermediates for oxidative coloration of hair |
| 12/23/2004 | US20040255402 Developer components and their use for dyeing keratinic fibers |
| 12/22/2004 | EP1487805A1 Pyrimidine derivatives |
| 12/22/2004 | EP1487796A1 Substituted biaryl amides as c5a receptor modulators |
| 12/22/2004 | CN1181069C Novel inhibitors of farnesyl-protein transferase |
| 12/21/2004 | US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders. |
| 12/21/2004 | US6833375 As inhibitors of the retinoic acid-metabolism, as drugs |